{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:44:01Z","timestamp":1761093841828,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.anai.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T11:32:46Z","timestamp":1510140766000},"page":"101-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Linear IgA bullous dermatosis: A rare manifestation of vancomycin hypersensitivity"],"prefix":"10.1016","volume":"120","author":[{"given":"Sravya","family":"Vinnakota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley R.","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2017.10.007_bib0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.0303-6987.2004.00190.x","article-title":"Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme","volume":"31","author":"Armstrong","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anai.2017.10.007_bib0015","first-page":"157","article-title":"Early diagnosis is key in vancomycin-induced linear iga bullous dermatosis and Stevens-Johnson syndrome","volume":"104","author":"Jones","year":"2004","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.anai.2017.10.007_bib0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.anai.2016.03.030","article-title":"Immune-mediated reactions to vancomycin: a systematic case review and analysis","volume":"116","author":"Minhas","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2017.10.007_bib0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2001.04492.x","article-title":"Vancomycin-induced linear iga disease with autoantibodies to bp180 and lad285","volume":"145","author":"Palmer","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2017.10.007_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature","volume":"30","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2017.10.007_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ced.13030","article-title":"Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap","volume":"42","author":"Adler","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.anai.2017.10.007_bib0040","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/bjd.14069","article-title":"Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis","volume":"175","author":"Tomida","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2017.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120617311699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120617311699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:17:03Z","timestamp":1761052623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120617311699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1081120617311699"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2017.10.007","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linear IgA bullous dermatosis: A rare manifestation of vancomycin hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}